Immunoassay Market Projected to Reach $47.5 Billion by 2031

The global immunoassay market is poised for significant expansion over the next five years, according to a new study by Wissen Research. The market's value is projected to increase from $35.5 billion in 2026 to $47.5 billion by 2031, reflecting an average annual growth rate (CAGR) of six percent during the forecast period.

Several factors are identified as key drivers for this growth. Increased healthcare investments, a rising prevalence of chronic diseases, and a growing demand for advanced diagnostic tools are contributing to the sector's development. Immunoassays play a crucial role in the diagnosis and monitoring of a wide range of medical conditions, supporting the market's ongoing expansion.

The Wissen Research analysis also highlights the impact of technological advancements. New and improved assay methodologies, coupled with increased automation in laboratory processes, are enhancing both efficiency and accuracy. These innovations are vital for maintaining market competitiveness and exploring new application areas.

Future market projections are based on current trends and anticipated technological shifts, underscoring the essential role of immunoassays in modern healthcare and diagnostics.